Foley Attorneys Highlighted for Perspective on New PBM Transparency Rules
February 19, 2026
BenefitsPro
Foley & Lardner LLP partner Nick Welle, senior counsel Hannah Demsien, and associate Iris Grossman were highlighted for their perspective on recent activity to increase pharmacy benefits manager (PBM) transparency in the BenefitsPro article, “New federal law clashes with DOL proposal over who pays for PBM audits.”
The authors present key takeaways and a helpful PBM reform cheat sheet chart summarizing new federal PBM audit rules in a Foley Health Care Law Today blog cited by BenefitsPro.
“The Foley & Lardner analysis has revealed a conflict between the new PBM audit laws and the draft DOL regulations,” BenefitsPro writes. “Different parties could end up paying for the PBM audits.”
(Subscription required)
People
Related News
September 18, 2026
In the News
Patrick Daugherty Authors Article on Navigating Proposed SEC Crypto Asset Regulations
Foley & Lardner LLP partner Patrick Daugherty authored the Columbia Law School’s Blue Sky Blog article, “How to Advise Token Developers in Light of Proposed SEC Regulation Crypto Assets.”
September 17, 2026
In the News
Foley Featured in Law.com for Guiding Kontoor Brands in Sale of Lee®
Foley & Lardner LLP partner Bryan Schultz is featured for leading the Foley deal team which advised Kontoor Brands in the sale of its Lee® business in Law.com's “How the Deal Got Done” series.
September 15, 2026
In the News
David Rosen Shares Insights on FDA Efforts to Accelerate Human Clinical Trials
Foley & Lardner LLP partner David Rosen shared insights in the recent Law360 article, “FDA Seeks Applications For Project To Speed Up Human Trials,” on the FDA's pilot program pairing pharmaceutical companies with research institutions to accelerate human clinical trials.